Innovative medical technologies have become more accessible, notes Dmytro Shymkiv
Oct 30, 2021
iCrowdMarketing powered by iCrowdNewswire
Ukrainians may easily join startup programs and participate in research to experience the new possibilities of medicine.This is the opinion of the chairman of the Darnitsa Group board of directors Dmytro Shymkiv that he voiced during the panel discussion HealthTech Talk, organized by the European Business Association with the support of the pharmaceutical company Darnitsa, and Philips.
The rapid development of Health Tech at the intersection of technology, medicine and pharmaceutics has expanded the accessibility of prevention and treatment of many diseases. Today, patients can choose among numerous tools for monitoring health biomarkers, and this has spurred a segment of early diagnosis of morbidity forming around them.
"The next trend is the use of artificial intelligence and machine learning, which enables making accurate recommendations resulting from processing biodata and the accumulated knowledge. This applies to cardiology, muscle condition, pressure parameters, and the like," stated the specialist.
According to Dmytro Shymkiv, round-the-clock monitoring of the well-being of millions of people will lead to the accumulation of a huge database, which will be analyzed by artificial intelligence (AI). Using it, we’ll open up new opportunities, in particular, the pharmaceutical company "Darnitsa" is studying the possibility of implementing AI to improve the functioning of the business as a whole, and to study the behavior and adherence of patients to treatment.
"We are considering the use of artificial intelligence in the field of in silico research. There are no appropriate developed platforms in Ukraine yet, so we are studying the solutions that exist in the US. The second direction is the search for new ways to use the currently known molecules," said the chairman of the Darnitsa Group board of directors.
The Covid-19 pandemic has accelerated the development of telemedicine. There are startups in Ukraine that invest in this area now. Telemedicine has grown by 35% -40% in the world under the influence of the coronavirus crisis. Personal contact with a doctor will soon become a thing of the past, and the initial reception "via a computer" will become an absolutely real story. "This will help to solve another problem - the shortage of doctors, which is observed all over the world," Dmytro Shymkiv predicts.
But a correct diagnosis is only half the battle. Patients often need long-term therapy or surgery. This is where, Dmytro Shymkiv believes, the future belongs to medical robots.
Among other important trends, the top manager named the so-called personalized drugs - systems for determining individual dosage and tracking dynamics of drug treatment, which, according to Shymkiv, are already being tested in Ukraine. And another trend - the sphere of digiceuticals (digital therapeutics - Ed.), this is when in addition to drugs and procedures, patients are prescribed certain mobile applications. The functionality of such applications can be aimed, in particular, at tracking and correcting the psychological conditions.
"One of the areas of implementation is PTSD, that is, a post-traumatic syndrome. Such applications are already being used today to treat, for example, neurosis," said Shymkiv. There are apps that track your sleep or apps that use a specially designed game to provide a calming effect on the brain. All top international pharmaceutical companies have digiceutical divisions. We are also looking into this, studying startups and opportunities for partnerships. We see ourselves as a company that soon will offer not only pills and infusions but also applications that can cure".